N
Exchange
—
Entity type
other
Fiscal year end
Dec 31
Headquarters
Ireland
Recent Filings
- 8-K21.9 KBNabriva Therapeutics Legacy plcJul 21, 4:39 PM ET·0001104659-17-046316
- 48.9 KBNabriva Therapeutics PlcJul 13, 9:22 PM ET·0001179110-17-010365
- 312.9 KBNabriva Therapeutics PlcJul 11, 4:32 PM ET·0001104659-17-044504
- 47.4 KBNabriva Therapeutics PlcJul 7, 9:29 PM ET·0001179110-17-010236
- 45.5 KBNabriva Therapeutics PlcJul 5, 8:15 PM ET·0001104659-17-043682
- 3/A13.8 KBNabriva Therapeutics PlcJun 28, 5:55 PM ET·0001104659-17-042159
- 410.1 KBNabriva Therapeutics PlcJun 28, 6:01 AM ET·0001104659-17-041909
- 48.4 KBNabriva Therapeutics PlcJun 27, 9:56 PM ET·0001104659-17-041907
- 48.3 KBNabriva Therapeutics PlcJun 27, 9:56 PM ET·0001104659-17-041906
- 410.9 KBNabriva Therapeutics PlcJun 27, 9:56 PM ET·0001104659-17-041905
Insiders
10- Bourdow Carrie L.Director
- Broom Colin MDDirector, Chief Executive Officer
- BURGESS DANIEL DDirector
- CORRIGAN MARKDirector
- Crotty RobertGeneral Counsel & Corp Secreta
- Gelone Steven P.Chief Development Officer
- HBM Healthcare Investments (Cayman) Ltd.10% Owner
- Khuong Chau QuangDirector, 10% Owner
- Lavino Francesco MariaChief Commercial Officer
- Rowland Charles A JrDirector
Tickers
No tickers on record
Addresses
business
56 FITZWILLIAM SQUARE
DUBLIN, L2, 2
mailing
1000 CONTINENTAL DRIVE SUITE 600
KING OF PRUSSIA, PA, 19406
Former Names
- Nabriva Therapeutics Plc2017-07-18